Two Cases of Long-Term Control of Metastatic Colorectal Cancer via FTD/TPI plus Bevacizumab in Elderly Patients

With advances in new cytotoxic drugs and molecular-targeted drugs, the prognosis of patients with metastatic colorectal cancer (mCRC) has improved. However, physicians often hesitate to administer intensive standard regimens to elderly patients with mCRC. Recently, first-line regimens that are effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibutani, Masatsune, Maeda, Kiyoshi, Nagahara, Hisashi, Fukuoka, Tatsunari, Iseki, Yasuhito, Matsutani, Shinji, Wang, En, Hirakawa, Kosei, Ohira, Masaichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323394/
https://www.ncbi.nlm.nih.gov/pubmed/30627095
http://dx.doi.org/10.1159/000493849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323394/
https://www.ncbi.nlm.nih.gov/pubmed/30627095
http://dx.doi.org/10.1159/000493849

Ejemplares similares